Tape stripping methods for analysis of skin disease and pathological skin state
First Claim
Patent Images
1. A method of detecting expression of genes in the skin, comprising:
- a) applying an adhesive tape to a target area of the skin in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises nucleic acid molecules; and
b) detecting expression of the nucleic acid molecules in the epidermal sample by determining a Ct value.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides non-invasive methods for detecting, monitoring, and diagnosing skin disease and pathological skin states such as irritated skin and psoriasis. The methods include using tape stripping to analyze expression in epidermal samples, of one or more skin markers. In illustrative examples, the tape stripping is performed using pliable tape that has a rubber adhesive. Furthermore, the present invention provides methods for predicting and monitoring response to therapy for a skin disease, such as psoriasis or dermatitis. Finally, the methods can include the use of a microarray.
-
Citations
39 Claims
-
1. A method of detecting expression of genes in the skin, comprising:
-
a) applying an adhesive tape to a target area of the skin in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises nucleic acid molecules; and b) detecting expression of the nucleic acid molecules in the epidermal sample by determining a Ct value. - View Dependent Claims (6, 7, 8, 9, 10)
-
-
2. A method for detecting a response of a subject to treatment for dermatitis, comprising:
-
a) treating the subject for dermatitis; b) applying an adhesive tape to irritated skin of the subject in a manner sufficient to isolate an epidermal sample, wherein the epidermal sample comprises nucleic acid molecules; and c) detecting expression of a keratin 10, keratin 16, or keratin 17 gene product, wherein an increase in expression is indicative of response of the subject to treatment for dermatitis, and wherein the method is performed prior to treatment and after treatment.
-
-
3. A method for detecting a response of a subject to treatment for dermatitis, comprising:
-
a) treating the subject for dermatitis; b) applying an adhesive tape to irritated skin of the subject in a manner sufficient to isolate an epidermal sample, wherein the epidermal sample comprises nucleic acid molecules; and c) detecting expression of a keratin 16 or keratin 17 gene product, wherein an increase in expression is indicative of response of the subject to treatment for dermatitis, and wherein the method is performed prior to treatment and after treatment.
-
-
4. A non-invasive method for isolating or detecting nucleic acid molecules from an epidermal sample of a psoriatic lesion of a human subject, comprising:
-
a) applying an adhesive tape to the psoriatic lesion of the subject in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises nucleic acid molecules; b) detecting expression of the nucleic acid molecules in the epidermal sample by determining a Ct value before and after treatment; c) detecting expression of the nucleic acid molecule by detecting a difference in a Δ
Ct value before and after treatment, wherein a Δ
Ct value is a difference in the number of amplification cycles required to reach a threshold signal level between the nucleic acid molecule and a control nucleic acid molecule. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
-
5. A method for diagnosing psoriasis in a human subject, comprising:
-
a) applying an adhesive tape to a lesion suspected of being a psoriatic lesion on the skin of the subject in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises a target nucleic acid molecule; b) detecting the target nucleic acid molecule; and c) comparing expression of the target nucleic acid molecule with expression of a control nucleic acid molecule in the same experiment using the same sample volumes and probes, wherein altered expression of the target nucleic acid molecule as compared with expression of the control nucleic acid molecule is determined by calculating a Ct value wherein altered expression is indicative of psoriasis, thereby diagnosing psoriasis in the subject. - View Dependent Claims (25, 26, 27, 28, 29)
-
-
30. A non-invasive method for identifying a predictive skin marker for response to treatment for a disease or pathological state, comprising:
-
a) applying an adhesive tape to the skin of a subject afflicted with the disease or pathological state at a first time point, in a manner sufficient to isolate an epidermal sample comprising nucleic acid molecules; b) treating the subject for the disease or pathological state; d) determining whether the disease or pathological state has responded to the treatment; and e) determining whether expression of a nucleic acid molecule in the epidermal sample is predictive of response to treatment, thereby identifying a skin marker for response to treatment. - View Dependent Claims (31, 32)
-
-
33. A non-invasive method for predicting response to treatment for a disease or pathological state, comprising:
-
a) applying an adhesive tape to the skin of a subject afflicted with the disease or pathological state in a manner sufficient to isolate an epidermal sample comprising nucleic acid molecules; b) detecting a target nucleic acid molecule in the epidermal sample, wherein expression of the target nucleic acid molecule is indicative of a response to treatment, thereby predicting response to treatment for the disease or pathological state. - View Dependent Claims (34, 35)
-
-
36. A non-invasive method for isolating or detecting a protein from an epidermal sample of a psoriatic lesion of a human subject, comprising:
-
a) applying an adhesive tape to the psoriatic lesion of the subject in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises cells from the stratum corneum of the subject; b) lysing the cells to extract a protein; and c) quantifying the protein, thereby isolating or detecting a protein in the epidermal sample. - View Dependent Claims (37)
-
-
38. A method for diagnosing psoriasis in a human subject, comprising:
-
a) applying an adhesive tape to a lesion suspected of being a psoriatic lesion on the skin of the subject in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises a target protein; b) detecting the target protein to determine the level of target protein in the sample; and c) comparing the level of target protein to a normal or standard protein profile in similar tissue, wherein an altered level of the target protein is indicative of psoriasis, thereby diagnosing psoriasis in the subject. - View Dependent Claims (39)
-
Specification